Abstract
Introduction
Change in the intracellular Ca 2+ concentration ([Ca 2+ ]i) is a major factor in the regulation of the contraction-relaxation cycle in smooth muscle cells. Increased [Ca 2+ ]i is caused by influx of Ca 2+ through Ca
2+
-permeable channels in the plasma membrane and/or release of Ca 2+ from Ca 2+ storage sites via either the process of Ca 2+ -induced Ca 2+ release (CICR) or of inositoltriphosphate (IP3)-induced Ca 2+ release (IICR) (Karaki et al., 1997) . On the other hand,
Correspondence to: Katsuhiko Muraki, Ph.D., Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabedori, Mizuhoku, Nagoya 467-8603, Japan Phone/Fax: +81-52-836-3432 e-mail: kmuraki@phar.nagoya-cu.ac.jp sequestration of Ca 2+ into the extracellular space and into intracellular organelles also affects the regulation of [Ca 2+ ]i in smooth muscle cells. Although it has been reported that ATP-dependent Ca 2+ -pumps in the plasma membrane and in the sarcoplasmic reticulum (SR) effectively extrude Ca 2+ (Kuriyama et al., 1998) , the involvement of a Na + /Ca 2+ exchanger (NCX) has been proposed (Ashida and Blaustein, 1987; Bova et al., 1989; Kim et al., 1999) . NCX catalyzes bidirectional electrogenic exchange of Na + for Ca 2+ across the plasma membrane. The direction of ion exchange is determined by the magnitude and orientation of the electrical and chemical gradients of Na + and Ca
. The function of NCX under physiological or pathological conditions is often difficult to define, because the membrane potential and/or intracellular concentrations of Na + ([Na + ]i) and [Ca 2+ ]i may vary and easily change in response to pharmacological and/or physiological stimuli (Imaizumi et al., 1998; Asada et al., 1999) . Moreover, the lack of potent and selective inhibitors of NCX has prevented the determination of the role and contribution of NCX in smooth muscle cells. Although XIP, a peptide which inhibits NCX, was introduced as a potent and relatively specific NCX inhibitor (Li et al., 1991) , its use is limited due to poor permeability into cells, high cationic sensitivity and interaction with calmoduline.
Therefore, the development of potent and specific inhibitors of NCX has been long-awaited, particularly as such inhibitors may assist in the study of the reverse mode of NCX, which contributes to elevation of [Ca 2+ ]i. This reverse mode may be involved in certain cardiovascular diseases such as hypertension and cardiac injury by Ca 2+ overload after ischemic reperfusion Lederer, 1999, Shigekawa and Iwamoto, 2001 ). KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl] ethyl] isothiourea methanesulphonate) is a novel compound which selectively inhibits the reverse mode of NCX in human embryo kidney (HEK) cells transfected with NCX c-DNA (Iwamoto et al., 1996b) . Moreover, it is likely that KB-R7943 effectively inhibits the reverse mode of NCX in cardiac cells (Iwamoto et al., 1996a) . However, studies to reveal the effects of KB-R7943 on vascular smooth muscle myocytes have been quite limited. In addition, it has been shown that Ca 2+ entry via the reverse mode of NCX in arterial myocytes is crucial for the activation of CICR but not sufficient for the global elevation of Ca 2+ (Ganitkevich and Isenberg, 1993) . In this study, we have examined the effects of KB-R7943 on carotid arterial myocytes isolated from the rat and compared these with those of pharmacological agents affecting Ca 2+ homeostasis in smooth muscle.
Methods

Cell-dispersion
All experiments were carried out in accordance with the principles established by the Science and International Affairs Bureau of the Japanese Ministry of Education, Science, Sports and Culture for the care and use of laboratory animals and also with the approval of the ethics committee of Nagoya City University. Male Wister ST strain rats (Japan SLC Inc., Shizuoka, Japan) weighing 140-270 g were anesthetized and killed by exsanguination. Segments of the left and right carotid artery which were approximately 1.5 cm in length were then excised. After removing the surrounding connective tissue and rubbing the inner wall of the vessel with a cotton pad to remove the endothelium, strips of approx. 0.7 cm length were incubated in nominally Ca 2+ and Mg 2+ free Hanks solution for 5 min and then for 45 min in a solution containing 2 mg/ml collagenase (Amano, Nagoya, Japan) and 1 mg/ml papain (Sigma, St Louis, USA) (Imaizumi et al., 1989; Muraki et al., 2003) . Thereafter, the enzyme-treated strips were mechanically agitated in fresh Ca 2+ and Mg 2+ free Hanks solution in the absence of digestive enzymes. Dissociated cells were used within 6 h of cell-dispersion. Ca 2+ and Mg 2+ free Hanks solution for cell-dispersion contained (mM) NaCl 137, KCl 5.4, Na2HPO4 0.168, KH2PO4 0.44, glucose 5.55 and NaHCO3 4.17.
Measurement of [Ca
2+
]i Single cells were loaded with 10 µM acetoxymethyl ester form of fura-2 (fura-2AM, Dojindo, Kumamoto, Japan) in physiological salt solution (PSS) for 45 min at room temperature. Measurement of fura-2 fluorescence was performed with an ARGUS50/CA imaging system (Hamamatsu Photonics, Japan, Muraki & Imaizumi, 2003) . Image acquisition was maintained at a frequency of one image every 5 seconds. The ratios of fluorescence intensity were then transformed into [Ca 2+ ]i using the following equation: [Ca 2+ ]i = Kd(R-Rmin)/(Rmax-R)(Sf2/Sb2). In the equation, Kd is the dissociation constant of Ca 2+ -fura-2 complex; R is the measured ratio; Rmin and Rmax are the fluorescence intensities determined by the addition of 1 mM EGTA (without Ca 2+ ) and 2 mM Ca 2+ , respectively, after the permeabilization of cells with 10 µM ionomycin; Sf2/ Sb2 is the ratio of the fluorescence proportionality coefficients obtained at 380 nm under Rmin and Rmax conditions.
Solution and drugs
The PSS contained (in mM) NaCl 138, KCl 5.9, CaCl2 1.8, MgSO4 1.2, glucose 10, HEPES 5 (pH was adjusted to 7.4 with 10 N NaOH). Ca 2+ -free PSS was prepared by the omission of CaCl2 from the PSS. Na + -free PSS (0 Na + PSS) was prepared by substituting N-methyl-D-glucamine (NMDG) for NaCl (pH was adjusted to 7.4 with HCl). In the present experiments, myocytes were treated with K + -free PSS for three minutes to inhibit the activity of the Na + -pump prior to perfusion with Na + -free PSS. The following drugs were used in this study: caffeine (Sigma), ryanodine (Sigma), D600 (methoxyverapamil, Sigma), ionomycin (Sigma), KB-R7943 (2-[2-[4-(4-nitrobenzyloxy) phenyl] ethyl] isothiourea methanesulphonate) (a gift by Organon). Drug concentrations are expressed as the final concentration in the bathing solution.
Statistics
Data are expressed as the mean ± S.E.M. Statistical significance between two or among multiple groups was determined using either the Student's t-or Tukey's tests respectively. Statistical significance at P values of 0.05 and 0.01 is indicated in figures and the text by * and ** respectively.
Results
The effect of removing Na + from the bathing solution on [Ca 2+ ]i in carotid arterial myocytes is illustrated in Fig. 1 . To inhibit Na + -pump activity, extracellular K + was removed from the bathing solution. This K + removal for three minutes had no effect on [Ca 2+ ]i (n>100). Thereafter, replacement of total Na + with equimolar NMDG (0 Na
]i from 131 ± 8 to 527 ± 43 nM (n=68).
To elucidate a possible contribution of the reverse mode of NCX on the Ca 2+ response to 0 Na + bathing solution, the effect of KB-R7943 is shown in Fig. 2 . After it was confirmed that 0 Na + caused an increase in [Ca 2+ ]i, the 2 nd challenge of 0 Na + was accomplished in the presence of KB-R7943 at a concentration range of from 0.1 to 30 µM (Figs. 2A, 2B and 2C). As shown in Fig.2D , KB-R7943 inhibited elevation of [Ca 2+ ]i by 0 Na + in a concentration dependent manner and the concentration of KB-R7943 required for 50% inhibition was calculated to be 3.5 µM. KB-R7943 was a reversible inhibitor because washout for 15 minutes resulted in recovery of the elevation of [Ca 2+ ]i by 0 Na + (Fig. 2C ). To examine whether the elevation of [Ca 2+ ]i induced by 0 Na + was due to Ca 2+ entry through VDCCs, myocytes were treated with D600 prior to testing with 0 Na + . As shown in Fig. 3A , 10 µM D600 did not affect the elevation (94.8 ± 11.2%, n=11, P>0.05). Moreover, a negative involvement of the SR in the Ca 2+ response to 0 Na + was confirmed in Fig. 3B by the use of ryanodine. In the presence of 10 µM ryanodine, a transient elevation of [Ca 2+ ]i by the 2nd challenge of 10 mM caffeine was abolished, hence indicating the dysfunction of SR during application of ryanodine. Even under these experimental conditions, the elevation of [Ca 2+ ]i by 0 Na + was not affected (112 ± 14.6%, n=6, P>0.05, Fig. 3B ). Nevertheless, 10 µM KB-R7943 significantly inhibited the elevation of [Ca 2+ ]i by 0 Na + in the presence of ryanodine (28.7 ± 9.0%), which was reversed by the removal of KB-R7943. On the other hand, application of 100 µM Cd 2+ , which is a non-specific inhibitor of NCX as well as of Ca 2+ entry pathways, effectively inhibited elevation of [Ca 2+ ]i by 0 Na + (17.4 ± 2.2%, n=5, P<0.01).
Discussion
The present study demonstrates that rat carotid arterial myocytes have a Ca 2+ response to external Na + deficiency. This Ca 2+ response is likely to be caused by activation of NCX in its reverse mode, because the elevation of [Ca 2+ ]i was effectively inhibited by KB-R7943 in a concentration range consistent with that necessary to block the NCX expressed in HEK cells (Iwamoto et al., 1996b) . It has been shown that KB-R7943 potently inhibited NCX-mediated Ca 2+ overload and membrane currents in cardiac myocytes and that the EC50 for the inhibition of reverse mode of NCX was 3-10 µM (Iwamoto et al., 2001) . Consistently, the EC50 of KB-R7943 needed to inhibit the Ca 2+ response of rat carotid arterial myocytes was 3.5 µM. Furthermore, the expression of the NCX protein is confirmed in vascular myocytes (Slodzinski and Blaustein, 1998) . Although we did not demonstrate the expression of NCX protein in the rat carotid artery, these lines of evidence indicate that activity of the reverse mode of NCX might be responsible for the Ca 2+ response to Na + deficiency in the rat carotid artery. In the present study, removal of Na + from the bathing solution in the absence of K + induced the elevation of [Ca 2+ ]i in more than 80% of the cells examined. In contrast, Na + deficiency in the presence of K + induced a slight elevation of [Ca 2+ ]i (<100 nM) in 10% of the cells. Consistently, simple removal of the external Na + elevated [Ca 2+ ]i in approximately 10% of the myocytes isolated from rabbit cerebral artery (Kim et al., 1999) . These results suggest that the activity of the Na + -pump plays an obligatory role in the activation of the reverse mode of NCX in vascular myocytes. Accumulation of [Na + ]i is not sufficient to activate the reverse mode of NCX, but simultaneous inhibition of the Na + -pump could be required for its activation in vascular myocytes.
It has been recently shown that 5 µM KB-R7943 has a non-specific action on the Ca 2+ response in cardiac myocytes where NCX1 was absent as a result of gene targeting (Reuter et al., 2002) . Moreover, Na + deficiency can release Ca 2+ from Ca 2+ stores in vascular smooth . In the presence of 10 µM D600 (A), 10 µM ryanodine (B) and 100 µM Cd 2+ (C), myocytes were superfused with 0 Na + bathing solution. , and thereby it is difficult to determine whether NCX works in a forward or reverse-direction during agonist stimulation. Although Ca 2+ efflux through NCX has been confirmed in cardiac mycoytes, it has not been concluded that the reverse mode of NCX occurs in these myocytes under physiological conditions (Blaustein and Lederer, 1999; Shigekawa and Iwamoto, 2001) . The decline of elevated [Ca 2+ ]i after stimulation with vasoconstrictors was reduced in vascular myocytes treated with antisense oligonucleotide of NCX1, indicating that NCX should contribute to the efflux of [Ca 2+ ]i during stimulation (Slodzinski and Blaustein, 1998). Moreover, it is possible that the reverse mode of NCX facilitates the tonic contraction caused by vasoconstrictors in some vascular smooth muscle as exposure to KB-R7943 reduced the contraction. The sensitivity to KB-R7943 of vaso-stimulantinduced contraction in the rat carotid artery has not been determined in the present study. Nevertheless, the present study strongly suggests the possible involvement of NCX in regulation of [Ca 2+ ]i in vascular smooth muscle cells presumably under physiological and pathophysiological conditions and therefore, modulators of NCX would be a useful pharmacological agent which will affect vascular muscle contraction and relaxation.
